BioCryst to Report Third Quarter 2022 Financial Results on November 1
RESEARCH TRIANGLE PARK, N.C., Oct. 18, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will report its third quarter 2022 financial results Tuesday, November 1, 2022.
- RESEARCH TRIANGLE PARK, N.C., Oct. 18, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will report its third quarter 2022 financial results Tuesday, November 1, 2022.
- BioCryst management will host a conference call and webcast at 8:30 a.m.
- ET that day to discuss the financial results and provide a corporate update.
- The live call may be accessed by dialing 866-374-5140 for domestic callers and 404-400-0571 for international callers and using conference ID 28663801#.